Company intelligence / Profile preview

BIOZOL

Eching, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

BIOZOL is a commercial distributor and service provider, not a clinical-stage drug development company. The company distributes over 25 million products from more than 250 suppliers worldwide for research and diagnostics applications.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: AntibodyEnzyme replacement therapyProteinRecombinant proteinVaccine
Industry: Protein Biomarker Diagnostics

Partnerships

Alpha Diagnostic InternationalEppendorf

Beyond the preview

Go deeper on BIOZOL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIOZOL.

Explore the full profile